These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
638 related items for PubMed ID: 16732755
1. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T. Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755 [Abstract] [Full Text] [Related]
2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B. J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099 [Abstract] [Full Text] [Related]
3. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR. Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598 [Abstract] [Full Text] [Related]
4. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA. Schizophr Res; 2003 Nov 01; 64(1):63-71. PubMed ID: 14511802 [Abstract] [Full Text] [Related]
5. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC. Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517 [Abstract] [Full Text] [Related]
6. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A. Pharmacopsychiatry; 2005 Sep 30; 38(5):214-9. PubMed ID: 16189748 [Abstract] [Full Text] [Related]
7. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients]. Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A. Psychiatr Pol; 2003 Sep 30; 37(6):977-88. PubMed ID: 14727370 [Abstract] [Full Text] [Related]
8. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL. Biol Psychiatry; 1998 Feb 15; 43(4):263-9. PubMed ID: 9513735 [Abstract] [Full Text] [Related]
9. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Schweinsburg BC, Taylor MJ, Alhassoon OM, Videen JS, Brown GG, Patterson TL, Berger F, Grant I. Alcohol Clin Exp Res; 2001 Jun 15; 25(6):924-34. PubMed ID: 11410730 [Abstract] [Full Text] [Related]
10. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Fujimoto T, Nakano T, Takano T, Takeuchi K, Yamada K, Fukuzako T, Akimoto H. Biol Psychiatry; 1996 Jul 01; 40(1):14-8. PubMed ID: 8780850 [Abstract] [Full Text] [Related]
11. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 01; 30(1):120-5. PubMed ID: 16236417 [Abstract] [Full Text] [Related]
12. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia. Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Siergiejczyk L, Czernikiewicz A, Walecki J. Med Sci Monit; 2007 May 01; 13 Suppl 1():11-6. PubMed ID: 17507879 [Abstract] [Full Text] [Related]
13. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C. Arch Gen Psychiatry; 2006 Sep 01; 63(9):969-76. PubMed ID: 16952999 [Abstract] [Full Text] [Related]
14. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings. Kim EA, Cheong HK, Choi DS, Sakong J, Ryoo JW, Park I, Kang DM. Neurotoxicology; 2007 Mar 01; 28(2):276-83. PubMed ID: 16824604 [Abstract] [Full Text] [Related]
15. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M. Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516 [Abstract] [Full Text] [Related]
16. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia. Tibbo P, Hanstock CC, Asghar S, Silverstone P, Allen PS. J Psychiatry Neurosci; 2000 Nov 30; 25(5):509-12. PubMed ID: 11109301 [Abstract] [Full Text] [Related]
17. Proton magnetic resonance spectroscopy of late-life major depressive disorder. Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT. Psychiatry Res; 2009 Jun 30; 172(3):210-4. PubMed ID: 19303260 [Abstract] [Full Text] [Related]
18. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW. Biol Psychiatry; 1998 Apr 01; 43(7):483-8. PubMed ID: 9547926 [Abstract] [Full Text] [Related]
19. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T. Psychiatry Res; 1995 Nov 10; 61(4):193-200. PubMed ID: 8748464 [Abstract] [Full Text] [Related]
20. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 10; 28(8):1313-22. PubMed ID: 15588758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]